Track topics on Twitter Track topics that are important to you
At Avidex, our focus is on the development of small molecule and protein therapeutics involving T cell receptors – either as drug targets or as the therapeutic molecule. Avidex has two key programmes leading to novel treatments in cancer, inflammation and autoimmune diseases.
57c Milton Park
Phone: 44 (0)1235 438600
Fax: 44 (0)1235 438601
Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...
MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...
JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
At Avidex, our focus is on the development of small molecule and protein therapeutics involving T cell receptors – either as drug targets or as the therapeutic molecule. Avidex has two key programme...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
Avidex is a drug discovery company with a unique, patented technology leading to the next generation of compounds forGraft rejection Autoimmune disease Cancer
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
Adaptimmune Limited is focused on the use of T cell therapy to treat HIV and cancer. It aims to utilize the body’s own machinery – the T lymphocyte cell – to target and destroy can...
We have published hundreds of Avidex Limited news stories on BioPortfolio along with dozens of Avidex Limited Clinical Trials and PubMed Articles about Avidex Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avidex Limited Companies in our database. You can also find out about relevant Avidex Limited Drugs and Medications on this site too.
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...